RSS-Feed abonnieren
Bitte kopieren Sie die angezeigte URL und fügen sie dann in Ihren RSS-Reader ein.
https://www.thieme-connect.de/rss/thieme/de/10.1055-s-00000059.xml
PDF herunterladen
Pneumologie 2023; 77(05): 269-302
DOI: 10.1055/a-2017-8971
DOI: 10.1055/a-2017-8971
Leitlinie
S1-Leitlinie Interdisziplinäre Diagnostik interstitieller Lungenerkrankungen im Erwachsenenalter
Consensus guideline on the interdisciplinary diagnosis of interstitial lung diseases
Zusammenfassung
Die Beurteilung von Patienten mit v. a. einer interstitiellen Lungenerkrankung (ILD) umfasst die Beurteilung klinischer, radiologischer und oft histopathologischer Daten. Da bislang noch keine dezidierten Empfehlungen für die Evaluation bei Verdacht auf eine ILD in Deutschland existierten, war es Ziel dieses interdisziplinären Konsensusstatements, eine praktische Orientierungshilfe für den klinischen Alltag in Bezug auf die interdisziplinäre Diagnostik der ILDs zu geben. Dazu gehören die umfassende klinisch-pneumologische und in vielen Fällen auch eine rheumatologische Beurteilung, radiologische Diagnostik sowie Probenentnahme zur histopathologischen Evaluation sowie die abschließende Diskussion im multidisziplinären Team.
Abstract
The evaluation of a patient with interstitial lung disease (ILD) includes assessment of clinical, radiological, and often histopathological data. As there were no specific recommendations to guide the evaluation of patients under the suspicion of an ILD within the German practice landscape, this position statement from an interdisciplinary panel of ILD experts provides guidance related to the diagnostic modalities which should be used in the evaluation of ILD. This includes clinical assessment rheumatological evaluation, radiological examinations, histopathologic sampling and the need for a final discussion in a multidisciplinary team.
Publikationsverlauf
Artikel online veröffentlicht:
28. März 2023
© 2023. Thieme. All rights reserved.
Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany
-
Literatur
- 1 Doyle TJ, Dellaripa PF. Lung Manifestations in the Rheumatic Diseases. Chest 2017; 152: 1283-1295
- 2 Wijsenbeek M, Cottin V. Spectrum of Fibrotic Lung Diseases. N Engl J Med 2020; 383: 958-968
- 3 Fischer A, Strek ME, Cottin V. et al. Proceedings of the American College of Rheumatology/Association of Physicians of Great Britain and Ireland Connective Tissue Disease-Associated Interstitial Lung Disease Summit: A Multidisciplinary Approach to Address Challenges and Opportunities. Arthritis Rheumatol 2019; 71: 182-195
- 4 Behr J, Prasse A, Wirtz H. et al. Survival and course of lung function in the presence or absence of antifibrotic treatment in patients with idiopathic pulmonary fibrosis: long-term results of the INSIGHTS-IPF registry. Eur Respir J 2020; 56: 1902279
- 5 Bouros D, Wells AU, Nicholson AG. et al. Histopathologic subsets of fibrosing alveolitis in patients with systemic sclerosis and their relationship to outcome. Am J Respir Crit Care Med 2002; 165: 1581-1586
- 6 Hoffmann-Vold AM, Allanore Y, Alves M. et al. Progressive interstitial lung disease in patients with systemic sclerosis-associated interstitial lung disease in the EUSTAR database. Ann Rheum Dis 2021; 80: 219-227
- 7 Hoffmann-Vold AM, Fretheim H, Halse AK. et al. Tracking Impact of Interstitial Lung Disease in Systemic Sclerosis in a Complete Nationwide Cohort. Am J Respir Crit Care Med 2019; 200: 1258-1266
- 8 Steen VD, Conte C, Owens GR. et al. Severe restrictive lung disease in systemic sclerosis. Arthritis Rheum 1994; 37: 1283-1289
- 9 Distler O, Highland KB, Gahlemann M. et al. Nintedanib for Systemic Sclerosis-Associated Interstitial Lung Disease. N Engl J Med 2019; 380: 2518-2528
- 10 Fischer A, Swigris JJ, Groshong SD. et al. Clinically significant interstitial lung disease in limited scleroderma: histopathology, clinical features, and survival. Chest 2008; 134: 601-605
- 11 Distler O, Volkmann ER, Hoffmann-Vold AM. et al. Current and future perspectives on management of systemic sclerosis-associated interstitial lung disease. Expert Rev Clin Immunol 2019; 15: 1009-1017
- 12 Winstone TA, Assayag D, Wilcox PG. et al. Predictors of mortality and progression in scleroderma-associated interstitial lung disease: a systematic review. Chest 2014; 146: 422-436
- 13 Distler O, Assassi S, Cottin V. et al. Predictors of progression in systemic sclerosis patients with interstitial lung disease. Eur Respir J 2020; 55: 1902026
- 14 Schinke S, Riemekasten G. [Systemic sclerosis]. Internist (Berl) 2019; 60: 1251-1269
- 15 van den Hoogen F, Khanna D, Fransen J. et al. 2013 classification criteria for systemic sclerosis: an American college of rheumatology/European league against rheumatism collaborative initiative. Ann Rheum Dis 2013; 72: 1747-1755
- 16 Kelly CA, Saravanan V, Nisar M. et al. Rheumatoid arthritis-related interstitial lung disease: associations, prognostic factors and physiological and radiological characteristics – a large multicentre UK study. Rheumatology 2014; 53: 1676-1682
- 17 Duarte AC, Porter JC, Leandro MJ. The lung in a cohort of rheumatoid arthritis patients—an overview of different types of involvement and treatment. Rheumatology 2019; 58: 2031-2038
- 18 Gabbay E, Tarala R, Will R. et al. Interstitial lung disease in recent onset rheumatoid arthritis. Am J Respir Crit Care Med 1997; 156: 528-535
- 19 Kim EJ, Collard HR, King TE. et al. Rheumatoid arthritis-associated interstitial lung disease: the relevance of histopathologic and radiographic pattern. Chest 2009; 136: 1397-1405
- 20 Strand MJ, Sprunger D, Cosgrove GP. et al. Pulmonary function and survival in idiopathic vs secondary usual interstitial pneumonia. Chest 2014; 146: 775-785
- 21 Bongartz T, Nannini C, Medina-Velasquez YF. et al. Incidence and mortality of interstitial lung disease in rheumatoid arthritis: a population-based study. Arthritis Rheum 2010; 62: 1583-1591
- 22 Giles JT, Danoff SK, Sokolove J. et al. Association of fine specificity and repertoire expansion of anticitrullinated peptide antibodies with rheumatoid arthritis associated interstitial lung disease. Ann Rheum Dis 2014; 73: 1487-1494
- 23 Zamora-Legoff JA, Krause ML, Crowson CS. et al. Patterns of interstitial lung disease and mortality in rheumatoid arthritis. Rheumatology (Oxford) 2017; 56: 344-350
- 24 Duarte AC, Sousa S, Cordeiro A. et al. FRI0138 Lung involvement in rheumatoid arthritis – a portuguese reality. Annals of the Rheumatic Diseases 2017; 76: 533
- 25 Barba T, Mainbourg S, Nasser M. et al. Lung Diseases in Inflammatory Myopathies. Semin Respir Crit Care Med 2019; 40: 255-270
- 26 Marie I, Hatron PY, Dominique S. et al. Short-term and long-term outcomes of interstitial lung disease in polymyositis and dermatomyositis: a series of 107 patients. Arthritis Rheum 2011; 63: 3439-3447
- 27 Marie I, Josse S, Hatron PY. et al. Interstitial lung disease in anti-Jo-1 patients with antisynthetase syndrome. Arthritis Care Res (Hoboken) 2013; 65: 800-808
- 28 Bauhammer J, Fiehn C. Antisynthetasesyndrome. Zeitschrift für Rheumatologie 2019; 78: 645-655
- 29 Chen Z, Cao M, Plana MN. et al. Utility of anti-melanoma differentiation-associated gene 5 antibody measurement in identifying patients with dermatomyositis and a high risk for developing rapidly progressive interstitial lung disease: a review of the literature and a meta-analysis. Arthritis Care Res (Hoboken) 2013; 65: 1316-1324
- 30 Csernok E, Hellmich B. ANCA-Diagnostik bei Vaskulitiden. Zeitschrift für Rheumatologie 2020; 79: 669-678
- 31 Bossuyt X, Cohen Tervaert JW, Arimura Y. et al. Position paper: Revised 2017 international consensus on testing of ANCAs in granulomatosis with polyangiitis and microscopic polyangiitis. Nat Rev Rheumatol 2017; 13: 683-692
- 32 Jennette JC, Falk R, Bacon P. et al. 2012 revised international chapel hill consensus conference nomenclature of vasculitides. Arthritis Rheum 2013; 65: 1-11
- 33 Schirmer JH, Aries PM, de Groot K. et al. S1-Leitlinie Diagnostik und Therapie der ANCA-assoziierten Vaskulitiden. Zeitschrift für Rheumatologie 2017; 76: 77-104
- 34 Comarmond C, Crestani B, Tazi A. et al. Pulmonary fibrosis in antineutrophil cytoplasmic antibodies (ANCA)-associated vasculitis: a series of 49 patients and review of the literature. Medicine (Baltimore) 2014; 93: 340-349
- 35 Arulkumaran N, Periselneris N, Gaskin G. et al. Interstitial lung disease and ANCA-associated vasculitis: a retrospective observational cohort study. Rheumatology (Oxford) 2011; 50: 2035-2043
- 36 Schirmer JH, Wright MN, Vonthein R. et al. Clinical presentation and long-term outcome of 144 patients with microscopic polyangiitis in a monocentric German cohort. Rheumatology (Oxford) 2016; 55: 71-79
- 37 Moiseev S, Cohen Tervaert JW, Arimura Y. et al. 2020 international consensus on ANCA testing beyond systemic vasculitis. Autoimmun Rev 2020; 19: 102618
- 38 Hooper C, Lee YC, Maskell N. Investigation of a unilateral pleural effusion in adults: British Thoracic Society Pleural Disease Guideline 2010. Thorax 2010; 65 (Suppl. 02) ii4-17
- 39 Hannah JR, D'Cruz DP. Pulmonary Complications of Systemic Lupus Erythematosus. Semin Respir Crit Care Med 2019; 40: 227-234
- 40 Mittoo S, Fell CD. Pulmonary manifestations of systemic lupus erythematosus. Semin Respir Crit Care Med 2014; 35: 249-254
- 41 Inoue T, Kanayama Y, Ohe A. et al. Immunopathologic studies of pneumonitis in systemic lupus erythematosus. Ann Intern Med 1979; 91: 30-34
- 42 Keane MP, Lynch JP. Pleuropulmonary manifestations of systemic lupus erythematosus. Thorax 2000; 55: 159-166
- 43 Ugarte-Gil MF, González LA, Alarcón GS. Lupus: the new epidemic. Lupus 2019; 28: 1031-1050
- 44 Flament T, Bigot A, Chaigne B. et al. Pulmonary manifestations of Sjögren's syndrome. Eur Respir Rev 2016; 25: 110-123
- 45 Kreider M, Highland K. Pulmonary involvement in Sjögren syndrome. Semin Respir Crit Care Med 2014; 35: 255-264
- 46 Mira-Avendano I, Abril A, Burger CD. et al. Interstitial Lung Disease and Other Pulmonary Manifestations in Connective Tissue Diseases. Mayo Clin Proc 2019; 94: 309-325
- 47 Parambil JG, Myers JL, Lindell RM. et al. Interstitial lung disease in primary Sjögren syndrome. Chest 2006; 130: 1489-1495
- 48 Reina D, Roig Vilaseca D, Torrente-Segarra V. et al. Sjögrenʼs syndrome-associated interstitial lung disease: A multicenter study. Reumatol Clin 2016; 12: 201-205
- 49 Tani C, Carli L, Vagnani S. et al. The diagnosis and classification of mixed connective tissue disease. J Autoimmun 2014; 48-49: 46-49
- 50 Ungprasert P, Crowson CS, Chowdhary VR. et al. Epidemiology of Mixed Connective Tissue Disease, 1985–2014: A Population-Based Study. Arthritis Care Res (Hoboken) 2016; 68: 1843-1848
- 51 Gunnarsson R, Aaløkken TM, Molberg Ø. et al. Prevalence and severity of interstitial lung disease in mixed connective tissue disease: a nationwide, cross-sectional study. Ann Rheum Dis 2012; 71: 1966-1972
- 52 Fagundes MN, Caleiro MT, Navarro-Rodriguez T. et al. Esophageal involvement and interstitial lung disease in mixed connective tissue disease. Respir Med 2009; 103: 854-860
- 53 Li H, Xiong Z, Liu J. et al. [Manifestations of the connective tissue associated interstitial lung disease under high resolution computed tomography]. Zhong Nan Da Xue Xue Bao Yi Xue Ban 2017; 42: 934-939
- 54 Hajas A, Szodoray P, Nakken B. et al. Clinical course, prognosis, and causes of death in mixed connective tissue disease. J Rheumatol 2013; 40: 1134-1142
- 55
Blanc PD,
Annesi-Maesano I,
Balmes JR.
et al. The Occupational Burden of Nonmalignant Respiratory Diseases. An Official American
Thoracic Society and European Respiratory Society Statement. Am J Respir Crit Care
Med 2019; 199: 1312-1334
MissingFormLabel
- 56 Müller-Lisse U. Grundlagen der Röntgendiagnostik des Thorax mit CT-Korrelation einzelner Fälle. Kapitel 1.11. Pneumologie – Lehrbuch für Atmungstherapeuten Deutsche Gesellschaft für Pneumologie und Beatmungsmedizin. Berlin: 2016: 107-121
- 57 Nowak D, Ochmann U, Mueller-Lisse UG. Berufskrankheiten der Atemwege und der Lunge. Der Internist 2021; 62: 906-920
- 58 Hering K, Hofmann-Preiß K, Kraus T. Update: Standardisierte CT-/HRCT-Klassifikation der Bundesrepublik Deutschland für arbeits-und umweltbedingte Thoraxerkrankungen. Der Radiologe 2014; 54: 363-384
- 59 Hering K, Hofmann-Preiß K. Pneumokoniosen erkennen und klassifizieren. Der Radiologe 2014; 54: 1189-1198
- 60 Hansell DM, Bankier AA, MacMahon H. et al. Fleischner Society: glossary of terms for thoracic imaging. Radiology 2008; 246: 697
- 61 Wormanns D, Hamer O. Glossar thoraxradiologischer Begriffe entsprechend der Terminologie der Fleischner Society. RöFo-Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren. Stuttgart: Thieme; 2015: 638-661
- 62 Yang M, Wang D, Gan S. et al. Increasing incidence of asbestosis worldwide, 1990–2017: results from the Global Burden of Disease study 2017. Thorax 2020; 75: 798-800
- 63 Hoy RF, Chambers DC. Silica‐related diseases in the modern world. Allergy 2020; 75: 2805-2817
- 64 Quirce S, Vandenplas O, Campo P. et al. Occupational hypersensitivity pneumonitis: an EAACI position paper. Allergy 2016; 71: 765-779
- 65 Klimek L, Vogelberg C, Werfel T. Weißbuch Allergie in Deutschland. Heidelberg: Springer; 2018
- 66 Sennekamp J, Müller-Wening D, Amthor M. et al. Empfehlungen zur Diagnostik der exogen-allergischen Alveolitis. Pneumologie 2007; 61: 52-56
- 67 Kumar A, Cummings KJ. Pulmonary alveolar proteinosis secondary to occupational exposure. Current Pulmonology Reports 2021; 10: 30-39
- 68 Hubbs AF, Kreiss K, Cummings KJ. et al. Flavorings-related lung disease: a brief review and new mechanistic data. Toxicol Pathol 2019; 47: 1012-1026
- 69 Kern D, Crausman R. Flock worker’s lung. Uptodate; 2020 https://uptodate.com
- 70 Lacasse Y, Selman M, Costabel U. et al. Clinical diagnosis of hypersensitivity pneumonitis. Am J Respir Crit Care Med 2003; 168: 952-958
- 71 Raghu G, Remy-Jardin M, Ryerson CJ. et al. Diagnosis of hypersensitivity pneumonitis in adults. An official ATS/JRS/ALAT clinical practice guideline. Am J Respir Crit Care Med 2020; 202: e36-e69
- 72 Lee T, Wraith D, Bennett C. et al. Budgerigar fancierʼs lung: The persistence of budgerigar precipitins and the recovery of lung function after cessation of avian exposure. Clin Allergy 1983; 13: 197-202
- 73 McSharry C, Dye GM, Ismail T. et al. Quantifying serum antibody in bird fanciersʼ hypersensitivity pneumonitis. BMC Pulm Med 2006; 6: 16
- 74 Salisbury ML, Myers JL, Belloli EA. et al. Diagnosis and treatment of fibrotic hypersensitivity pneumonia. Where we stand and where we need to go. Am J Respir Crit Care Med 2017; 196: 690-699
- 75 Cormier Y, Bélanger J, Durand P. Factors influencing the development of serum precipitins to farmerʼs lung antigen in Quebec dairy farmers. Thorax 1985; 40: 138-142
- 76 Cormier Y, Letourneau L, Racine G. Significance of precipitins and asymptomatic lymphocytic alveolitis: a 20‐yr follow-up. Eur Respir J 2004; 23: 523-525
- 77 Fenoglio C-M, Reboux G, Sudre B. et al. Diagnostic value of serum precipitins to mould antigens in active hypersensitivity pneumonitis. Eur Respir J 2007; 29: 706-712
- 78 Raulf M, Joest M, Sander I. et al. Update of reference values for IgG antibodies against typical antigens of hypersensitivity pneumonitis. Allergo Journal International 2019; 28: 192-203
- 79 Harari S, Wells AU, Wuyts WA. et al. The 6-min walk test as a primary end-point in interstitial lung disease. Eur Respir Rev 2022; 31: 220087
- 80 Kabitz H, Windisch W. Respiratory muscle testing: state of the art. Pneumologie 2007; 61: 582-587
- 81 Windisch W, Dreher M, Geiseler J. et al. S2k-leitlinie: Nichtinvasive und invasive Beatmung als Therapie der chronischen respiratorischen Insuffizienz – Revision 2017. Pneumologie 2017; 71: 722-795
- 82 Kreuter M, Müller-Ladner U, Costabel U. et al. The diagnosis and treatment of pulmonary fibrosis. Dtsch Arztebl Int 2021; 118: 152-162
- 83 Schiza S, Mermigkis C, Margaritopoulos GA. et al. Idiopathic pulmonary fibrosis and sleep disorders: no longer strangers in the night. Eur Respir Rev 2015; 24: 327-339
- 84 Dreher M, Ekkernkamp E, Schmoor C. et al. Pulmonary rehabilitation and noninvasive ventilation in patients with hypercapnic interstitial lung disease. Respiration 2015; 89: 208-213
- 85 Koschel D, Handzhiev S, Wiedemann B. et al. Acute effects of NPPV in interstitial lung disease with chronic hypercapnic respiratory failure. Respir Med 2010; 104: 291-295
- 86 Guler SA, Am Hur S, Stickland MK. et al. Survival after inpatient or outpatient pulmonary rehabilitation in patients with fibrotic interstitial lung disease: a multicentre retrospective cohort study. Thorax 2022; 77: 589-595
- 87 Schegerer A, Loose R, Heuser LJ. et al. Diagnostic reference levels for diagnostic and interventional X-ray procedures in Germany: update and handling. RöFo-Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren. Stuttgart: Thieme; 2019: 739-751
- 88 Nagel H, Hering K, Hieckel H. et al. Protokollempfehlungen der AG DRauE zur Durchführung von Low-Dose-Volumen-HRCT-Untersuchungen der Lunge. Fortschr Röntengstr 2017; 189: 553-575
- 89 Sodickson A, Baeyens PF, Andriole KP. et al. Recurrent CT, cumulative radiation exposure, and associated radiation-induced cancer risks from CT of adults. Radiology 2009; 251: 175
- 90 Brenner DJ, Hall EJ. Computed tomography – an increasing source of radiation exposure. N Engl J Med 2007; 357: 2277-2284
- 91 Wormanns D, Hamer O. Glossary of terms for thoracic imaging – German version of the Fleischner Society recommendations. Rofo 2015; 187: 638-661
- 92 Meyer KC, Raghu G, Baughman RP. et al. An official American Thoracic Society clinical practice guideline: the clinical utility of bronchoalveolar lavage cellular analysis in interstitial lung disease. Am J Respir Crit Care Med 2012; 185: 1004-1014
- 93 Hetzel J, Kreuter M, Kähler CM. et al. Bronchoscopic performance of bronchoalveolar lavage in germany – a call for standardization. Sarcoidosis Vasc Diffuse Lung Dis 2021; 38: e2021003
- 94 Haslam PL, Baughman RP. Report of ERS Task Force: guidelines for measurement of acellular components and standardization of BAL. Eur Respir J 1999; 14: 245-248
- 95 Costabel U. Deutsche Gesellschaft für Pneumologie: Empfehlungen zur diagnostischen bronchoalveolaren lavage. Pneumologie 1993; 47: 607-619
- 96 Costabel U, Guzman J, Bonella F. et al. Bronchoalveolar lavage in other interstitial lung diseases. Semin Respir Crit Care Med 2007; 28: 514-524
- 97 Bonella F, Ohshimo S, Bauer P. et al. Bronchoalveolar lavage. Eur Respir Mon 2010; 48: 59-72
- 98 Costabel U, Bross K, Rühle K. et al. Ia-like antigens on T-cells and their subpopulations in pulmonary sarcoidosis and in hypersensitivity pneumonitis: analysis of bronchoalveolar and blood lymphocytes. Am Rev Respir Dis 1985; 131: 337-342
- 99 Barrera L, Mendoza F, Zuñiga J. et al. Functional diversity of T-cell subpopulations in subacute and chronic hypersensitivity pneumonitis. Am J Respir Crit Care Med 2008; 177: 44-55
- 100 Behr J, Günther A, Costabel U. S2K-Leitlinie zur Diagnostik der idiopathischen Lungenfibrose [German Guideline for Idiopathic Pulmonary Fibrosis]. Pneumologie 2020; 74: 263-293
- 101 Adderley N, Humphreys CJ, Barnes H. et al. Bronchoalveolar lavage fluid lymphocytosis in chronic hypersensitivity pneumonitis: a systematic review and meta-analysis. Eur Respir J 2020; 56: 2000206
- 102 Bonella F, Costabel U. The perpetual enigma of bronchoalveolar lavage fluid lymphocytosis in chronic hypersensitivity pneumonitis: is it of diagnostic value?. Eur Respir J 2020; 56: 2001534
- 103 Tzilas V, Tzouvelekis A, Bouros E. et al. Diagnostic value of BAL lymphocytosis in patients with indeterminate for usual interstitial pneumonia imaging pattern. Eur Respir J 2019; 54: 1901144
- 104 Ryu YJ, Chung MP, Han J. et al. Bronchoalveolar lavage in fibrotic idiopathic interstitial pneumonias. Respir Med 2007; 101: 655-660
- 105 De Sadeleer LJ, Hermans F, De Dycker E. et al. Impact of BAL lymphocytosis and presence of honeycombing on corticosteroid treatment effect in fibrotic hypersensitivity pneumonitis: a retrospective cohort study. Eur Respir J 2020; 55: 1901983
- 106 Yamagata A, Arita M, Tachibana H. et al. Impact of bronchoalveolar lavage lymphocytosis on the effects of anti-inflammatory therapy in idiopathic non-specific interstitial pneumonia, idiopathic pleuroparenchymal fibroelastosis, and unclassifiable idiopathic interstitial pneumonia. Respir Res 2021; 22: 115
- 107 Tomassetti S, Colby TV, Wells AU. et al. Bronchoalveolar lavage and lung biopsy in connective tissue diseases, to do or not to do?. Ther Adv Musculoskelet Dis 2021; 13
- 108 Hecker E, Gesierich W. Mediastinales Staging. Allgemein- und Viszeralchirurgie up2date 2021; 15: 513-529
- 109 Bradley B, Branley H, Egan J. et al. British Thoracic Society Interstitial Lung Disease Guideline Group, British Thoracic Society Standards of Care Committee; Thoracic Society of Australia; New Zealand Thoracic Society; Irish Thoracic Society. Interstitial lung disease guideline: the British Thoracic Society in collaboration with the Thoracic Society of Australia and New Zealand and the Irish Thoracic Society. Thorax 2008; 63: v1-v58
- 110 Descombes E, Gardiol D, Leuenberger P. Transbronchial lung biopsy: an analysis of 530 cases with reference to the number of samples. Monaldi Arch Chest Dis 1997; 52: 324-329
- 111 Curley FJ, Johal JS, Burke ME. et al. Transbronchial lung biopsy: can specimen quality be predicted at the time of biopsy?. Chest 1998; 113: 1037-1041
- 112 de Boer S, Milne DG, Zeng I. et al. Does CT scanning predict the likelihood of a positive transbronchial biopsy in sarcoidosis?. Thorax 2009; 64: 436-439
- 113 Halme M, Piilonen A, Taskinen E. Comparison of endobronchial and transbronchial biopsies with high‐resolution CT (HRCT) in the diagnosis of sarcoidosis Note. Apmis 2001; 109: 289-294
- 114 Sehgal IS, Bal A, Dhooria S. et al. A prospective randomized controlled trial comparing the efficacy and safety of cup vs alligator forceps for performing transbronchial lung biopsy in patients with sarcoidosis. Chest 2016; 149: 1584-1586
- 115 Jabbardarjani H, Eslaminejad A, Mohammadtaheri Z. et al. The effect of cup versus alligator forceps on the results of transbronchial lung biopsy. J Bronchology Interv Pulmonoly 2010; 17: 117-121
- 116 Chugh K, Jatwani S. Transbronchial biopsy vs. bronchoalveolar lavage in interstitial lung disease. Curr Opin Pulm Med 2022; 28: 3-8
- 117 Raghu G, Remy-Jardin M, Richeldi L. et al. Idiopathic pulmonary fibrosis (an update) and progressive pulmonary fibrosis in adults: an official ATS/ERS/JRS/ALAT clinical practice guideline. Am J Respir Crit Care Med 2022; 205: e18-e47
- 118 Morell F, Reyes L, Doménech G. et al. Diagnoses and diagnostic procedures in 500 consecutive patients with clinical suspicion of interstitial lung disease. Archivos de Bronconeumología (English Edition) 2008; 44: 185-191
- 119 Han Q, Luo Q, Chen X. et al. The evaluation of clinical usefulness of transbrochoscopic lung biopsy in undefined interstitial lung diseases: a retrospective study. Clin Respir J 2017; 11: 168-175
- 120 Sindhwani G, Shirazi N, Sodhi R. et al. Transbronchial lung biopsy in patients with diffuse parenchymal lung disease without ‘idiopathic pulmonary fibrosis pattern’ on HRCT scan-Experience from a tertiary care center of North India. Lung India 2015; 32: 453
- 121 Sheth JS, Belperio JA, Fishbein MC. et al. Utility of transbronchial vs surgical lung biopsy in the diagnosis of suspected fibrotic interstitial lung disease. Chest 2017; 151: 389-399
- 122 Pourabdollah M, Shamaei M, Karimi S. et al. Transbronchial lung biopsy: the pathologistʼs point of view. Clin Respir J 2016; 10: 211-216
- 123 Ramaswamy A, Homer R, Killam J. et al. Comparison of transbronchial and cryobiopsies in evaluation of diffuse parenchymal lung disease. J Bronchology Interv Pulmonol 2016; 23: 14-21
- 124 Wahidi MM, Argento AC, Mahmood K. et al. Comparison of Forceps, Cryoprobe, and Thoracoscopic Lung Biopsy for the Diagnosis of Interstitial Lung Disease – The CHILL Study. Respiration 2022; 101: 394-400
- 125 Raghu G, Remy-Jardin M, Myers JL. et al. Diagnosis of idiopathic pulmonary fibrosis. An official ATS/ERS/JRS/ALAT clinical practice guideline. Am J Respir Crit Care Med 2018; 198: e44-e68
- 126 Chami HA, Diaz-Mendoza J, Chua A. et al. Transbronchial biopsy and cryobiopsy in the diagnosis of hypersensitivity pneumonitis among patients with interstitial lung disease. Ann Am Thorac Soc 2021; 18: 148-161
- 127 Adams TN, Newton CA, Batra K. et al. Utility of bronchoalveolar lavage and transbronchial biopsy in patients with hypersensitivity pneumonitis. Lung 2018; 196: 617-622
- 128 Pérez ERF, Travis WD, Lynch DA. et al. Diagnosis and evaluation of hypersensitivity pneumonitis: CHEST guideline and expert panel report. Chest 2021; 160: e97-e156
- 129 Crouser E, Maier L, Wilson K. et al. on behalf of the American Thoracic Society. Assembly on Clinical Problems. Diagnosis and Detection of Sarcoidosis. An Official American Thoracic Society Clinical Practice Guideline. Am J Respir Crit Care Med 2020; 201: e26
- 130 Häntschel M, Eberhardt R, Petermann C. et al. Diagnostic Yield of Transbronchial Lung Cryobiopsy Compared to Transbronchial Forceps Biopsy in Patients with Sarcoidosis in a Prospective, Randomized, Multicentre Cross-Over Trial. J Clin Med 2021; 10: 5686
- 131 Gupta N, Finlay GA, Kotloff RM. et al. Lymphangioleiomyomatosis diagnosis and management: high-resolution chest computed tomography, transbronchial lung biopsy, and pleural disease management. An Official American Thoracic Society/Japanese Respiratory Society Clinical Practice Guideline. Am J Respir Crit Care Med 2017; 196: 1337-1348
- 132 Ye L, Jin M, Bai C. Clinical analysis of patients with pulmonary lymphangioleiomyomatosis (PLAM) in mainland China. Respir Med 2010; 104: 1521-1526
- 133 Meraj R, Wikenheiser-Brokamp KA, Young LR. et al. Utility of transbronchial biopsy in the diagnosis of lymphangioleiomyomatosis. Front Med 2012; 6: 395-405
- 134 Rittirak W, Sompradeekul S. Diagnostic yield of fluoroscopy-guided transbronchial lung biopsy in non-endobronchial lung lesion. J Med Assoc Thai 2007; 90: 68-73
- 135 Ost DE, Ernst A, Lei X. et al. Diagnostic yield and complications of bronchoscopy for peripheral lung lesions. Results of the AQuIRE registry. Am J Respir Crit Care Med 2016; 193: 68-77
- 136 Trapnell BC, Nakata K, Bonella F. et al. Pulmonary alveolar proteinosis. Nature Reviews Disease Primers 2019; 5: 1-17
- 137 Azuma K, Takimoto T, Kasai T. et al. Diagnostic yield and safety of bronchofiberscopy for pulmonary alveolar proteinosis. Respiratory Investigation 2021; 59: 757-765
- 138 Babiak A, Hetzel J, Krishna G. et al. Transbronchial cryobiopsy: a new tool for lung biopsies. Respiration 2009; 78: 203-208
- 139 Behr J, Günther A, Bonella F. et al. S2K guideline for diagnosis of idiopathic pulmonary fibrosis. Respiration 2021; 100: 238-271
- 140 Kheir F, Uribe Becerra JP, Bissell B. et al. Transbronchial lung cryobiopsy in patients with interstitial lung disease: a systematic review. Ann Am Thorac Soc 2022; 19: 1193-1202
- 141 Hetzel J, Maldonado F, Ravaglia C. et al. Transbronchial cryobiopsies for the diagnosis of diffuse parenchymal lung diseases: expert statement from the cryobiopsy working group on safety and utility and a call for standardization of the procedure. Respiration 2018; 95: 188-200
- 142 Maldonado F, Danoff SK, Wells AU. et al. Transbronchial cryobiopsy for the diagnosis of interstitial lung diseases: CHEST guideline and expert panel report. Chest 2020; 157: 1030-1042
- 143 Raghu G, Collard HR, Egan JJ. et al. An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management. Am J Respir Crit Care Med 2011; 183: 788-824
- 144 Raghu G, Remy-Jardin M, Myers JL. et al. Diagnosis of Idiopathic Pulmonary Fibrosis. An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline. Am J Respir Crit Care Med 2018; 198: e44-e68
- 145 Gaensler EA, Carrington CB. Open biopsy for chronic diffuse infiltrative lung disease: clinical, roentgenographic, and physiological correlations in 502 patients. Ann Thorac Surg 1980; 30: 411-426
- 146 Burt ME, Flye MW, Webber BL. et al. Prospective evaluation of aspiration needle, cutting needle, transbronchial, and open lung biopsy in patients with pulmonary infiltrates. Ann Thorac Surg 1981; 32: 146-153
- 147 Miller RR, Nelems B, Muller NL. et al. Lingular and right middle lobe biopsy in the assessment of diffuse lung disease. Ann Thorac Surg 1987; 44: 269-273
- 148 Krasna MJ, White CS, Aisner SC. et al. The role of thoracoscopy in the diagnosis of interstitial lung disease. Ann Thorac Surg 1995; 59: 348-351
- 149 Miller JD, Urschel JD, Cox G. et al. A randomized, controlled trial comparing thoracoscopy and limited thoracotomy for lung biopsy in interstitial lung disease. Ann Thorac Surg 2000; 70: 1647-1650
- 150 Flint A, Martinez FJ, Young ML. et al. Influence of sample number and biopsy site on the histologic diagnosis of diffuse lung disease. Ann Thorac Surg 1995; 60: 1605-1607 discussion 1607–1608
- 151 Fibla JJ, Brunelli A, Allen MS. et al. Do the number and volume of surgical lung biopsies influence the diagnostic yield in interstitial lung disease? A propensity score analysis. Archivos de Bronconeumología (English Edition) 2015; 51: 76-79
- 152 Khalil M, Cowen M, Chaudhry M. et al. Single versus multiple lung biopsies for suspected interstitial lung disease. Asian Cardiovasc Thorac Ann 2016; 24: 788-791
- 153 Monaghan H, Wells AU, Colby TV. et al. Prognostic implications of histologic patterns in multiple surgical lung biopsies from patients with idiopathic interstitial pneumonias. Chest 2004; 125: 522-526
- 154 Flaherty KR, Travis WD, Colby TV. et al. Histopathologic variability in usual and nonspecific interstitial pneumonias. Am J Respir Crit Care Med 2001; 164: 1722-1727
- 155 Bradley B, Branley HM, Egan JJ. et al. Interstitial lung disease guideline: the British Thoracic Society in collaboration with the Thoracic Society of Australia and New Zealand and the Irish Thoracic Society. Thorax 2008; 63 (Suppl. 05) v1-v58
- 156 Raghu G, Remy-Jardin M, Myers J. et al. American Thoracic Society. Diagnosis of Idiopathic Pulmonary Fibrosis. An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline. Am J Respir Crit Care Med 2018; 198: e44--e68
- 157 Hutchinson JP, McKeever TM, Fogarty AW. et al. Surgical lung biopsy for the diagnosis of interstitial lung disease in England: 1997–2008. Eur Respir J 2016; 48: 1453-1461
- 158 Kayatta MO, Ahmed S, Hammel JA. et al. Surgical biopsy of suspected interstitial lung disease is superior to radiographic diagnosis. Ann Thorac Surg 2013; 96: 399-401
- 159 Tacconi F, Pompeo E. Non-intubated video-assisted thoracic surgery: where does evidence stand?. J Thorac Dis 2016; 8: S364-S375
- 160 Lohser J, Slinger P. Lung injury after one-lung ventilation: a review of the pathophysiologic mechanisms affecting the ventilated and the collapsed lung. Anesthesia & Analgesia 2015; 121: 302-318
- 161 Pompeo E, Sorge R, Akopov A. et al. Non-intubated thoracic surgery – a survey from the European Society of Thoracic Surgeons. Ann Transl Med 2015; 3: 37
- 162 Galetin T, Lopez-Pastorini A, Kosse N. et al. Video-assisted Thoracoscopic Surgery in Local Anaesthesia and Analgosedation – a Survey of the Members of the German Society of Thoracic Surgeons. Zentralbl Chir 2019; 145: 278-283
- 163 Pompeo E, Rogliani P, Cristino B. et al. Awake thoracoscopic biopsy of interstitial lung disease. Ann Thorac Surg 2013; 95: 445-452
- 164 Kurihara C, Tolly B, DeWolf A. et al. Thoracoscopic lung biopsy under regional anesthesia for interstitial lung disease. Reg Anesth Pain Med 2020; 45: 255-259
- 165 Peng G, Liu M, Luo Q. et al. Spontaneous ventilation anesthesia combined with uniportal and tubeless thoracoscopic lung biopsy in selected patients with interstitial lung diseases. J Thorac Dis 2017; 9: 4494-4501
- 166 Kim TH, Cho JH. Nonintubated Video-Assisted Thoracoscopic Surgery Lung Biopsy for Interstitial Lung Disease. Thorac Surg Clin 2020; 30: 41-48
- 167 Bedetti B, Patrini D, Bertolaccini L. et al. Uniportal non-intubated thoracic surgery. J Vis Surg 2018; 4: 18
- 168 Gonzalez-Rivas D, Bonome C, Fieira E. et al. Non-intubated video-assisted thoracoscopic lung resections: the future of thoracic surgery?. Eur J Cardiothorac Surg 2016; 49: 721-731
- 169 Cherchi R, Grimaldi G, Pinna-Susnik M. et al. Retrospective outcomes analysis of 99 consecutive uniportal awake lung biopsies: a real standard of care?. Journal of Thoracic Disease 2020; 12: 4717
- 170 Jeon C-S, Yoon DW, Moon SM. et al. Non-intubated video-assisted thoracoscopic lung biopsy for interstitial lung disease: a single-center experience. J Thorac Dis 2018; 10: 3262
- 171 Kiss G, Castillo M. Nonintubated anesthesia in thoracic surgery: general issues. Ann Transl Med 2015; 3: 110
- 172 Han D, Cao Y, Wu H. et al. Uniportal video-assisted thoracic surgery for the treatment of lung cancer: a consensus report from Chinese Society for Thoracic and Cardiovascular Surgery (CSTCVS) and Chinese Association of Thoracic Surgeons (CATS). Transl Lung Cancer Res h 2020; 9: 971-987
- 173 Travis WD, Costabel U, Hansell DM. et al. An official American Thoracic Society/European Respiratory Society statement: update of the international multidisciplinary classification of the idiopathic interstitial pneumonias. Am J Respir Crit Care Med 2013; 188: 733-748
- 174 Länger F, Stark H, Braubach P. et al. Schädigungsmuster interstitieller Lungenerkrankungen. Der Pathologe 2018; 39: 262-271
- 175 Länger F, Stark H, Braubach P. et al. Injury patterns in interstitial lung diseases. Der Pathologe 2018; 39: 262-271
- 176 Behr J, Günther A, Bonella F. et al. S2K-Leitlinie zur Diagnostik der idiopathischen Lungenfibrose. Pneumologie 2020; 74: 263-293
- 177 Furini F, Carnevale A, Casoni GL. et al. The role of the multidisciplinary evaluation of interstitial lung diseases: systematic literature review of the current evidence and future perspectives. Front Med (Lausanne) 2019; 6: 246
- 178 Flaherty KR, King Jr TE, Raghu G. et al. Idiopathic interstitial pneumonia: what is the effect of a multidisciplinary approach to diagnosis?. Am J Respir Crit Care Med 2004; 170: 904-910
- 179 Flaherty KR, Andrei A-C, King Jr TE. et al. Idiopathic interstitial pneumonia: do community and academic physicians agree on diagnosis?. Am J Respir Crit Care Med 2007; 175: 1054-1060
- 180 Jo HE, Glaspole IN, Levin KC. et al. Clinical impact of the interstitial lung disease multidisciplinary service. Respirology 2016; 21: 1438-1444
- 181 Chaudhuri N, Spencer L, Greaves M. et al. A review of the multidisciplinary diagnosis of interstitial lung diseases: a retrospective analysis in a single UK specialist centre. J Clin Med 2016; 5: 66
- 182 Biglia C, Ghaye B, Reychler G. et al. Multidisciplinary management of interstitial lung diseases: a real-life study. Sarcoidosis Vasc Diffuse Lung Dis 2019; 36: 108-115
- 183 Walsh SL, Wells AU, Desai SR. et al. Multicentre evaluation of multidisciplinary team meeting agreement on diagnosis in diffuse parenchymal lung disease: a case-cohort study. Lancet Respir Med 2016; 4: 557-565
- 184 Valeyre D. Towards a better diagnosis of idiopathic pulmonary fibrosis. Eur Respir Rev 2011; 20: 108-113
- 185 Spagnolo P, Tonelli R, Cocconcelli E. et al. Idiopathic pulmonary fibrosis: diagnostic pitfalls and therapeutic challenges. Multidiscip Respir Med 2012; 7: 42
- 186 Nathan SD, Shlobin OA, Weir N. et al. Long-term course and prognosis of idiopathic pulmonary fibrosis in the new millennium. Chest 2011; 140: 221-229
- 187 Valeyre D. Towards a better diagnosis of idiopathic pulmonary fibrosis. Eur Respir Rev 2011; 20: 108-113
- 188 Flaherty KR, Travis WD, Colby TV. et al. Histopathologic variability in usual and nonspecific interstitial pneumonias. Am J Respir Crit Care Med 2001; 164: 1722-1727
- 189 Nicholson A, Addis B, Bharucha H. et al. Inter-observer variation between pathologists in diffuse parenchymal lung disease. Thorax 2004; 59: 500-505
- 190 Raghu G, Flaherty KR, Lederer DJ. et al. Use of a molecular classifier to identify usual interstitial pneumonia in conventional transbronchial lung biopsy samples: a prospective validation study. Lancet Respir Med 2019; 7: 487-496
- 191 Morell F, Villar A, Montero MA. et al. Chronic hypersensitivity pneumonitis in patients diagnosed with idiopathic pulmonary fibrosis: a prospective case-cohort study. Lancet Respir Med 2013; 1: 685-694
- 192 Park JH, Kim DS, Park IN. et al. Prognosis of fibrotic interstitial pneumonia: idiopathic versus collagen vascular disease-related subtypes. Am J Respir Crit Care Med 2007; 175: 705-711
- 193 Strange C, Highland KB. Interstitial lung disease in the patient who has connective tissue disease. Clin Chest Med 2004; 25: 549-559
- 194 Tan E, Feltkamp T, Smolen J. et al. Range of antinuclear antibodies in “healthy” individuals. Arthritis Rheum 1997; 40: 1601-1611
- 195 Solomon DH, Kavanaugh AJ, Schur PH. et al. Evidence‐based guidelines for the use of immunologic tests: antinuclear antibody testing. Arthritis Rheum 2002; 47: 434-444
- 196 Salisbury ML, Myers JL, Belloli EA. et al. Diagnosis and Treatment of Fibrotic Hypersensitivity Pneumonia. Where We Stand and Where We Need to Go. Am J Respir Crit Care Med 2017; 196: 690-699
- 197 Sennekamp J, Müller-Wening D, Amthor M. et al. Guidelines for diagnosing extrinsic allergic alveolitis (hypersensitivity pneumonitis)(German Extrinsic Allergic Alveolitis Study Group). Pneumologie 2007; 61: 52-56
- 198 Buendía-Roldán I, Santiago-Ruiz L, Pérez-Rubio G. et al. A major genetic determinant of autoimmune diseases is associated with the presence of autoantibodies in hypersensitivity pneumonitis. Eur Respir J 2020; 56: 1901380
- 199 Guler SA, Ellison K, Algamdi M. et al. Heterogeneity in unclassifiable interstitial lung disease. A systematic review and meta-analysis. Ann Am Thorac Soc 2018; 15: 854-863
- 200 Raghu G, Amatto VC, Behr J. et al. Comorbidities in idiopathic pulmonary fibrosis patients: a systematic literature review. Eur Respir J 2015; 46: 1113-1130